HLN · Pharma and healthcare · one day
Haleon (HLN): news on Monday 26 October 2026
News from the 24 hours to Monday morning, 26 October 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage was divided between Zacks lowering Haleon to Strong Sell, having previously rated it Hold, and screening articles naming it among British AI-related healthcare shares worth watching. The downgrade outweighed the mildly positive watchlist mentions, so the tone is slightly negative.
What drove it
- Zacks downgrade
- AI healthcare stock lists
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Tue 20 Oct | +3.5 | 2 |
| Wed 21 Oct | +5.5 | 4 |
| Thu 22 Oct | +6.0 | 2 |
| Fri 23 Oct | +3.7 | 6 |
| Sat 24 Oct | +2.3 | 5 |
| Sun 25 Oct | +5.7 | 3 |
| Mon 26 Oct | −1.2 | 3 |
2 stories · 3 headlines · strongest first
Pharma and healthcare on 26 OctoberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Haleon is named among three UK healthcare shares linked to AI worth watching +2.82 headlines today · Two pieces list Haleon among AI healthcare stocks. | ||
| +3.0 | Haleon highlighted as a leading British AI healthcare stock; mildly positive framing. | |
| +2.7 | Haleon named top of a watchlist of British AI healthcare stocks. | |
| Zacks downgrades Haleon to Strong Sell −7.01 headline today · Ad-hoc-news reports the downgrade from Hold. | ||
| −7.0 | Zacks downgrade to Strong Sell signals deteriorating analyst view of Haleon. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Haleon: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.